...
首页> 外文期刊>Medicine. >Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia
【24h】

Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia

机译:血小板减少症儿童发病系统狼疮性红斑狼疮的硬膜镜和视网膜出血的成功治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION:Thrombocytopenia (TP) is a common complication of childhood-onset systemic lupus erythematosus (SLE), and can range from mild to life-threatening. However, severe TP with multiple hemorrhagic complications is very rare and often predicts a poor prognosis. We describe a 12-year-old Chinese girl who had a history of idiopathic thrombocytopenic purpura who developed SLE that presented as subdural hemorrhage and retinal hemorrhage because of severe TP.PATIENT CONCERNS:A 12-year-old girl was admitted into our hospital because of fever, purpura, and gum bleeding lasting for 12?days. She had a history of idiopathic thrombocytopenic purpura 2?years ago previously.DIAGNOSIS:SLE was diagnosed according to American College of Rheumatology classification criteria. Subdural hemorrhage and retinal hemorrhage were diagnosed based on brain MRI and funduscopy. Severe TP was defined as platelet count 1-year follow-up.CONCLUSION:Isolated TP may be an early symptom of childhood-onset SLE . A child with severe TP is prone to develop life-threatening hemorrhagic complications. Glucocorticoids and combined immunosuppressive drugs had a durable response to refractory TP in this patient with no adverse effects.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:介绍:血小板减少症(TP)是儿童疫苗发病系统狼疮红斑狼疮(SLE)的常见并发症,可以从轻度到危及生命。然而,具有多种出血性并发症的严重TP是非常罕见的并且通常预测预后差。我们描述了一个12岁的中国女孩,患有特发性血小板细胞紫癜的历史,他开发了呈现为软血管出血和视网膜出血的历史,因为严重的tp.Patient问题:一个12岁的女孩被送进了我们的医院,因为发烧,紫癜和口香糖出血持续12次?天。她患有特发性血小板减少紫癜2的历史2?几年前以前。根据美国风湿病学院诊断诊断出诊断症状。基于脑MRI和眼底诊断,诊断了硬膜镜出血和视网膜出血。严重的TP被定义为血小板计数1年后续后续。结论:分离的TP可能是幼儿发作SLE的早期症状。具有严重TP的儿童容易发生危及生命的出血性并发症。糖皮质激素和合并的免疫抑制药物对该患者的难治性TP具有耐用的反应,没有不良反应.Copyright? 2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号